Clinical Trial Update: A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution [Phase 2]

View source ↗

Summary

Phase 2 trial update for ATI-50002 topical solution in androgenetic alopecia has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• ATI-50002 topical solution (ATI-50002)

Snippet

Sponsor: Aclaris Therapeutics, Inc. | Conditions: Androgenetic Alopecia | Phase 2 | Status: COMPLETED | Results posted: 2020-12-09